All are curative treatment modalities for hepatocellular carcinoma, EXCEPT:
## **Core Concept**
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver, and its treatment modalities vary based on the stage and underlying liver function. Curative treatment options for HCC include surgical resection, liver transplantation, and ablative therapies. Understanding the indications and limitations of each treatment option is crucial for managing HCC effectively.
## **Why the Correct Answer is Right**
Option refers to Radiofrequency Ablation (RFA), which is indeed a curative treatment modality for HCC, especially for early-stage tumors. Surgical resection and liver transplantation are also established curative treatments. On the other hand, option is Transarterial Chemoembolization (TACE), which is generally considered a palliative treatment for HCC, not curative. TACE involves delivering chemotherapy and embolizing agents directly to the tumor via the hepatic artery, aiming to control tumor growth and alleviate symptoms rather than achieve a cure.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Surgical resection is a curative treatment for HCC, particularly for patients with early-stage disease and well-preserved liver function. It offers a chance for a cure by completely removing the tumor.
- **Option B:** Liver transplantation is considered a curative option for HCC, especially for those with early-stage tumors that meet specific criteria (e.g., Milan Criteria). It addresses both the tumor and the underlying liver disease.
- **Option C:** Radiofrequency Ablation (RFA) is a minimally invasive technique that uses heat to destroy cancer cells and is considered curative for small HCC tumors.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the choice of treatment for HCC depends on the tumor stage, liver function, and performance status of the patient. For early-stage HCC, curative options like resection, transplantation, and ablative therapies are considered. TACE, on the other hand, is typically reserved for patients with intermediate-stage disease who are not candidates for curative treatments.
## **Correct Answer:** . Transarterial Chemoembolization (TACE)